Calumet reported a strong Q3 performance, surpassing analyst expectations with an EPS of $2.91 versus the estimated $1.63, and EBITDA of $347 million compared to the expected $269 million. The Specialty Products segment benefited from limited global paraffinic base oil supply and steady demand, maintaining volumes above 20,000 barrels per day. Montana Renewables is increasing capacity with a stronger capital structure after a recent deal, providing flexibility for future operations or sale. The company’s shares are valued at $73.50 each, supported by solid cash flows and reduced debt, though stock volatility remains a risk factor.
Despite Calumet's strong quarterly results, its stock price on Pluang is down 9.23% at USD 39.35. The stock trades well below its 52-week high of USD 59.05 as of Nov 07, 2026 06:41 WIB.
